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The Opioid Crisis
Abstract
Opioid use and addiction have reached epidemic proportions in Philadelphia, making drug overdose
involving opioids a leading cause of death. Both pharmaceutical and illicit opioids contribute to this crisis.
Opioid sales in Philadelphia more than doubled between 2000 and 2012, and health care providers
continue to prescribe opioid pain medication in greater quantities than medically appropriate. The peak
age group for overdoses is 45-54, an older age group than previously seen. Over-prescribing of opioids
contributes to the recruitment of adults into drug dependence. While use of opioid pain medications
usually does not lead to opioid use disorder, four out of five heroin users nationwide transitioned from
original use of prescription medications. Heroin is easy to obtain, potent and cheap compared to
prescription pain medications. There are estimated to be at least 70,000 heroin users in Philadelphia.
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DATA BRIEF
THE OPIOID CRISIS
Written by Caroline Stark and Sara Solomon with consultation from Carolyn Cannuscio,
Jeffrey Hom, and Zachary Meisel

BACKGROUND
Opioid use and addiction have
reached epidemic proportions in
Philadelphia, making drug overdose
involving opioids a leading cause of
death. Both pharmaceutical and illicit
opioids contribute to this crisis. Opioid
sales in Philadelphia more than
doubled between 2000 and 2012,
and health care providers continue
to prescribe opioid pain medication
in greater quantities than medically
appropriate1. The peak age group
for overdoses is 45-54, an older age
group than previously seen2. Overprescribing of opioids contributes to

the recruitment of adults into drug
dependence. While use of opioid pain
medications usually does not lead to
opioid use disorder, four out of five
heroin users nationwide transitioned
from original use of prescription
medications3. Heroin is easy to obtain,
potent and cheap compared to
prescription pain medications. There
are estimated to be at least 70,000
heroin users in Philadelphia4.
Opioid use disorder and overdose
significantly impact individuals
and health system utilization in
Philadelphia. In 2015, there were over
6,500 emergency department visits

Figure 1: Rates of opioid-related overdose deaths in Philadelphia, 2016*
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*Philadelphia residents only. The epidemic of overdoses from opioids in Philadelphia.
Philadelphia Department of Public Health 2016 http://www.phila.gov/health/pdfs/chart%20v2e7.pdf
†Non-Hispanic

“We need to figure out how
we can best assess and share
opioid risk information to
patients and their providers
in a way that meets patients’
own needs for pain control
without having to give them
excess medications that they
may not need, want, use and
could lead to dependency and
addiction.”
—CPHI Senior Fellow,
Zachary Meisel, MD
for opioid overdoses across the city5.
Further, for each opioid-related death,
there were about 12 opioid-related
emergency department visits. 2016
drug overdose death rates increased
across all demographic groups.
Deaths in men were three times more
common than deaths in women. While
all races saw an increase in opioid
related overdose rates in 2016, whites
were disproportionately affected
(Figure 1).
Addiction also impacts the families
and children of users. Consequences
of drug misuse that impact families
include compromised health, higher
health care costs, violence, child
abuse and neglect6. Neonatal
abstinence syndrome (NAS) can
result from opioid use during
pregnancy and may interfere with a
child’s brain development and later
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cognitive functioning and behavior. In Philadelphia, the rate of NAS increased
more than three-fold from 2002 to 20157. Adverse childhood experiences
(ACE) such as growing up with household substance abuse can have long-term
effects on children’s health and make substance abuse later in life more likely.
Approximately 35% of almost 2,000 Philadelphians surveyed grew up with
substance abuse in their households8.
The epidemic also affects the criminal justice system. Substance use disorder
prevalence is higher among prison populations than among the general
population and incarceration itself is a risk factor for developing substance
use disorder9. Substance use disorders can increase risk of incarceration and
probability of arrest for nonviolent or drug-related offenses10.

RECOMMENDATIONS FROM
11
THE OPIOID TASK FORCE

STRATEGY 1: PREVENTION AND EDUCATION
■

Conduct a consumer-directed
media campaign about opioid risks.

■

Improve health care professional
education.

■

Conduct a public education
campaign about naloxone, which is
used to reverse opioid overdose.

■

Establish insurance policies that
support safer opioid prescribing
and appropriate treatment.

■

Destigmatize opioid use disorder
and its treatment.

■

Expand treatment access and
capacity.

■

Embed withdrawal management
into all levels of care, with an
emphasis on recovery initiation.

■

Expand naloxone availability.

■

Further explore comprehensive
user engagement site(s) (i.e. safe
injection sites).

■

Establish a coordinated rapid
response to “outbreaks.”

■

Implement “warm handoffs” to
treat substance use disorder after
overdose.

Address homelessness among
opioid users.

■

Expand the court’s capacity for
diversion to treatment.

■

Provide safe housing, recovery, and
vocational supports.

■

Expand enforcement capacity in
key areas.

■

Incentivize providers to enhance
the quality of substance use
disorder screening, treatment, and
workforce.

■

Provide substance use disorder
assessment and treatment in
Philadelphia Department of Prisons.

■

ÎÎ Develop an opioid epidemic data
report to establish a baseline and
monitor the epidemic

ÎÎ Integrate data across systems
to optimize care for affected
individuals
ÎÎ Develop an evaluation plan that
assesses the progress and impact
of the Mayor’s Opioid Task Force
Report
ÎÎ Model the program on
other successful “disease”specific program areas within
Philadelphia’s health department

ABOUT CPHI
The Center for Public Health
Initiatives works to advance the
science of public health.

STRATEGY 2: TREATMENT
Increase the provision of
medication-assisted treatment.

The City will succeed at implementing
these steps only with the cooperation
of many organizations and individuals.
Monitoring, reporting, and surveillance
will be established to:

ÎÎ Establish use of real-time data to
support a rapid response plan

Mayor James Kenney introduced a coordinated effort to confront this issue, with
The Mayor’s Task Force to Combat the Opioid Epidemic in Philadelphia. The task
force developed a plan to reduce opioid use disorder and associated morbidity
and mortality, with the following recommendations:

■

IMPLEMENTATION,
MONITORING, AND
EVALUATION

CPHI was founded in 2007 by the
University of Pennsylvania to act
as an interdisciplinary public health
center that brings together faculty,
staff, and students from across
Penn’s campus. The mission of
CPHI is to educate and train new
and emerging public health
leaders, foster multi-disciplinary
collaborations, and promote
excellence in public health
research and community
partnerships.
ANATOMY CHEMISTRY BUILDING,
ROOM 148
3620 HAMILTON WALK
PHILADELPHIA, PA 19104
CPHI.UPENN.EDU
T: 215-746-3467
F: 215-573:9025
@CPHIatUPenn
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